Developer docs
API playgroundTry for free, no card

Search company profiles

STIMIT

Full company profile

uuid00045gh

Namestring
STIMIT
Legal namestring
STIMIT AG
Websiteurl
stimit.com
Company typeenum
Private
Founded yearint
2018
Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBiel, Switzerland
HQ citystring
Biel
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
diaphragm stimulation therapy, mechanical ventilation support, intensive care medical devices, non-invasive respiratory therapy, critical care medtech
Industry1 code
PRIMARYHLAHAGAK
Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Critical Care Medical Devices
No data
Cost components5 values
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

STIMIT develops and manufactures the STIMIT Activator 1, a medical device that uses non-invasive magnetic field technology to stimulate diaphragm muscles in mechanically ventilated intensive care patients. The device is intended for use in ICUs and other critical care settings to address muscle atrophy and respiratory dysfunction associated with prolonged mechanical ventilation. The Activator 1 received market approval in Canada.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

STIMIT is a Swiss medtech startup that developed a single core medical device product—the STIMIT Activator 1—which provides non-invasive magnetic field technology for diaphragm muscle stimulation in mechanically ventilated intensive care patients. The company has been acquired by Hamilton Medical as of February 2026.

Product and service1 record
1STIMIT Activator 1
CategoryCritical Care Medical Devices
Description

A medical device that uses non-invasive magnetic field technology to stimulate diaphragm muscles in mechanically ventilated intensive care patients, intended for use by hospitals, ICUs, and critical care teams to prevent diaphragm atrophy and support respiratory recovery. The device received market approval in Canada.

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-23
Description

STIMIT was acquired by Hamilton Medical, a Swiss-based manufacturer of critical care ventilation solutions. The integration combines both companies' expertise in critical care technology to drive joint growth. STIMIT's competencies in non-invasive magnetic field technologies for diaphragm stimulation will be integrated into the Hamilton Group to advance their positions in the critical care technology market.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Lungpacer Medical develops diaphragm stimulation therapy for mechanically ventilated patients, directly addressing the same ICU use case as STIMIT's Activator 1. It is one of the closest functional competitors in respiratory muscle stimulation for ventilated patients.

TypeDirect peer
Description

Synapse Biomedical manufactures the NeuRx Diaphragm Pacing System for stimulating the diaphragm in ventilator-dependent patients. While its core system is invasive, it competes in the same clinical problem space and is frequently referenced in the diaphragm stimulation market.

TypeEmerging player
Description

Liberate Medical develops non-invasive neuromuscular electrical stimulation for ventilated patients to improve weaning outcomes. It overlaps with STIMIT's mission of non-invasive diaphragm/respiratory muscle stimulation in ICU settings.

TypeBroad incumbent
Description

Hamilton Medical is a global manufacturer of critical care ventilators and is also STIMIT's parent company post-acquisition. It represents the incumbent ICU ventilation platform into which STIMIT's technology is being integrated.

TypeBroad incumbent
Description

Getinge is a major ICU ventilation and critical care equipment manufacturer with a broad portfolio including ventilators used in the same ICU environments as STIMIT's target customers.

6Dräger
TypeBroad incumbent
Description

Dräger is a leading global manufacturer of ICU ventilators and patient monitoring solutions, serving the same hospital ICU customers that STIMIT targets with its diaphragm stimulation therapy.

TypeBroad incumbent
Description

Medtronic operates a significant critical care and respiratory therapies business (including ventilators acquired via Covidien and other respiratory interventions). Its scale and ICU relationships make it a strategic comparable for the critical care respiratory market STIMIT addresses.

TypeBroad incumbent
Description

Philips is a global player in hospital respiratory care and ICU patient monitoring, serving the same ICU customer base as STIMIT. Its broad portfolio positions it as a potential integrator of complementary respiratory muscle stimulation technologies.

TypeEmerging player
Description

Respinova is an emerging medtech company developing non-invasive pulmonary airway stimulation technologies for COPD and respiratory patients. While its primary focus is chronic obstructive disease, its stimulation-based approach to respiratory therapy is conceptually adjacent to STIMIT's work.

TypeEmerging player
Description

Atrotech develops targeted nerve and muscle stimulation technologies with potential applications in respiratory and critical care. It represents an emerging adjacent stimulation player whose modality and clinical focus overlap with STIMIT's non-invasive diaphragm stimulation platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

STIMIT

Critical Care Medical Devicesstimit.com

STIMIT firmographics

Firmographics
Name
STIMIT
Legal name
STIMIT AG
Website
https://stimit.com
Company type
Private
Founded year
2018
Operating status
Acquired
Headcount range
1–10 employees
Ownership category
akta.pro rank

STIMIT industry classification

Industry
Product category
Critical Care Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHAGAK
Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

Keywords

  • Diaphragm stimulation therapy
  • Mechanical ventilation support
  • Intensive care medical devices
  • Non-invasive respiratory therapy
  • Critical care medtech

Where STIMIT is headquartered

Location

Headquarters

HQ city
Biel
HQ country
Switzerland
HQ region
Europe

Markets served

STIMIT business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

STIMIT product offering

Product offering

Core offering

STIMIT develops and manufactures the STIMIT Activator 1, a medical device that uses non-invasive magnetic field technology to stimulate diaphragm muscles in mechanically ventilated intensive care patients. The device is intended for use in ICUs and other critical care settings to address muscle atrophy and respiratory dysfunction associated with prolonged mechanical ventilation. The Activator 1 received market approval in Canada.

Product overview

STIMIT is a Swiss medtech startup that developed a single core medical device product—the STIMIT Activator 1—which provides non-invasive magnetic field technology for diaphragm muscle stimulation in mechanically ventilated intensive care patients. The company has been acquired by Hamilton Medical as of February 2026.

Differentiator

Problem solved

Functional benefit

Products and services

  • STIMIT Activator 1 A medical device that uses non-invasive magnetic field technology to stimulate diaphragm muscles in mechanically ventilated intensive care patients, intended for use by hospitals, ICUs, and critical care teams to prevent diaphragm atrophy and support respiratory recovery. The device received market approval in Canada.

Companies that use STIMIT

Customer profile

Segments1 record

Ideal customer profiles1 record

STIMIT technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

STIMIT partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Hamilton MedicalcoreStrategic or Co-development Partner · 23 February 2026STIMIT was acquired by Hamilton Medical, a Swiss-based manufacturer of critical care ventilation solutions. The integration combines both companies' expertise in critical care technology to drive joint growth. STIMIT's competencies in non-invasive magnetic field technologies for diaphragm stimulation will be integrated into the Hamilton Group to advance their positions in the critical care technology market.

Recent moves5 records

Expansion highlights5 records

STIMIT competitors and assessment

Company assessment

Direct peers

  • Lungpacer Medical: Lungpacer Medical develops diaphragm stimulation therapy for mechanically ventilated patients, directly addressing the same ICU use case as STIMIT's Activator 1. It is one of the closest functional competitors in respiratory muscle stimulation for ventilated patients.
  • Synapse Biomedical: Synapse Biomedical manufactures the NeuRx Diaphragm Pacing System for stimulating the diaphragm in ventilator-dependent patients. While its core system is invasive, it competes in the same clinical problem space and is frequently referenced in the diaphragm stimulation market.

Emerging players

  • Liberate Medical: Liberate Medical develops non-invasive neuromuscular electrical stimulation for ventilated patients to improve weaning outcomes. It overlaps with STIMIT's mission of non-invasive diaphragm/respiratory muscle stimulation in ICU settings.
  • Respinova: Respinova is an emerging medtech company developing non-invasive pulmonary airway stimulation technologies for COPD and respiratory patients. While its primary focus is chronic obstructive disease, its stimulation-based approach to respiratory therapy is conceptually adjacent to STIMIT's work.
  • Atrotech: Atrotech develops targeted nerve and muscle stimulation technologies with potential applications in respiratory and critical care. It represents an emerging adjacent stimulation player whose modality and clinical focus overlap with STIMIT's non-invasive diaphragm stimulation platform.

Broad incumbents

  • Hamilton Medical: Hamilton Medical is a global manufacturer of critical care ventilators and is also STIMIT's parent company post-acquisition. It represents the incumbent ICU ventilation platform into which STIMIT's technology is being integrated.
  • Getinge: Getinge is a major ICU ventilation and critical care equipment manufacturer with a broad portfolio including ventilators used in the same ICU environments as STIMIT's target customers.
  • Dräger: Dräger is a leading global manufacturer of ICU ventilators and patient monitoring solutions, serving the same hospital ICU customers that STIMIT targets with its diaphragm stimulation therapy.
  • Medtronic: Medtronic operates a significant critical care and respiratory therapies business (including ventilators acquired via Covidien and other respiratory interventions). Its scale and ICU relationships make it a strategic comparable for the critical care respiratory market STIMIT addresses.
  • Philips: Philips is a global player in hospital respiratory care and ICU patient monitoring, serving the same ICU customer base as STIMIT. Its broad portfolio positions it as a potential integrator of complementary respiratory muscle stimulation technologies.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

STIMIT financial estimates

Financial estimate

Revenue estimate

Valuation estimate

STIMIT leadership team

Management profile

Number of profiles

Profiles2 records

STIMIT funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

STIMIT M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about STIMIT

What does STIMIT do?

STIMIT develops and manufactures the STIMIT Activator 1, a medical device that uses non-invasive magnetic field technology to stimulate diaphragm muscles in mechanically ventilated intensive care patients. The device is intended for use in ICUs and other critical care settings to address muscle atrophy and respiratory dysfunction associated with prolonged mechanical ventilation. The Activator 1 received market approval in Canada.

Is STIMIT a public or private company?

STIMIT is a private company. It is classified as corporate owned and is currently acquired.

When was STIMIT founded?

STIMIT was founded in 2018. It employs 1 to 10 people.

Where is STIMIT based?

STIMIT is headquartered in Biel, Switzerland, in the Europe region.

Who are STIMIT's main competitors?

Direct peers on record are Lungpacer Medical and Synapse Biomedical. Emerging players are Liberate Medical, Respinova and Atrotech. Broad incumbents are Hamilton Medical, Getinge, Dräger, Medtronic and Philips.

Does STIMIT have an API?

No public API is recorded for STIMIT.

What industry is STIMIT in?

STIMIT's product category is Critical Care Medical Devices. Its primary akta.pro industry code is HLAHAGAK, Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
startupticker.chFemale Founder News #23February's female founder ecosystem saw over twenty startups advance through grants and innovation loans, alongside two healthtech acquisitions signalling continued sector consolidation. Hamilton Medical acquired Bern-based STIMIT AG to integrate its competencies into the Hamilton Group, while Swiss Rockets acquired U.S. life sciences company Complete Genomics to support targeted cancer therapies and next-generation vaccine development. Global health and logistics company Axmed received a $6 million grant from the Gates Foundation to scale its essential medicines sourcing and distribution platform across Africa.startupticker.chHigh survival rateSwiss start-up liquidations increased for the third consecutive year in 2025, though the 10-year liquidation rate of about 18% remains significantly lower than the bankruptcy rate of new businesses outside the start-up sector, a trend attributed to Switzerland's favourable funding landscape. ETH Zurich set a record with 46 new ventures originated from the university in 2025, while Venture Kick announced it will support 16% more start-ups in 2026 and this week awarded CHF 150,000 to Baxiva. After a four-year hiatus, four Swiss start-ups—DePoly, Neutrality, Pregnolia, and Verity—were selected for EIC Accelerator funding, and two exits were recorded as medtech start-up Stimit was acquired by Hamilton Medical and fintech Kaspar& was taken over by Liberty Vorsorge.VenturelabSTIMIT acquired by Hamilton MedicalSwiss medtech startup STIMIT, a Venture Kick winner and Venture Leaders participant, has been acquired by Hamilton Medical. The integration of STIMIT into the Hamilton Group will occur gradually, combining both companies' expertise in critical care technology to drive joint growth. The acquisition marks a strategic step for both companies in advancing their positions in the critical care technology market.startupticker.chHamilton Medical acquires STIMIT AGHamilton Medical, a Swiss-based manufacturer of critical care ventilation solutions, has completed the acquisition of STIMIT AG, also based in Biel, Switzerland. STIMIT AG develops non-invasive magnetic field technologies that stimulate diaphragm muscles in mechanically ventilated intensive care patients, with its STIMIT Activator 1 device having received market approval in Canada. The integration aims to strategically combine both companies' competencies and foster joint growth in the respiratory care market.Newswireneurocare group AG and STIMIT AG announce strategic cooperationneurocare group AG and STIMIT AG announced a strategic cooperation, with neurocare's subsidiary MAG&More producing stimulators and sharing control know-how. The deal aims to scale production of stimulation products and generate recurring OEM revenue. It also supports STIMIT's development of a diaphragm stimulation solution for ventilated patients.GlobeNewswireneurocare group AG and STIMIT AG announce strategic cooperationneurocare group AG and STIMIT AG announced a strategic cooperation, with neurocare's subsidiary MAG&More producing stimulators and sharing control know-how. The deal aims to scale production of stimulation products and generate recurrent OEM revenue. It also supports STIMIT's development of a diaphragm stimulation solution for ventilated patients.PR NewswireMechanical Ventilator Market Size Worth $4.22 Billion by 2030: Grand View Research, Inc.Grand View Research Inc. released a market report projecting the global mechanical ventilator market to reach $4.22 billion by 2030, growing at a CAGR of 4.8% from 2022 to 2030, driven by COVID-19's impact, rising COPD incidence, respiratory emergencies, and technological innovation in respiratory care devices. Critical care ventilators held over 35% market share in 2021, while non-invasive ventilation modes dominated revenue and are expected to witness the fastest growth, with home healthcare emerging as a high-growth segment due to cost efficiency. Notable product developments include InnAccel Technologies' April 2020 launch of a non-invasive ICU ventilation system engineered in India, Spicejet's August 2020 introduction of Spiceoxy portable ventilation device, and Drägerwerk AG & Co. KGaA's April 2021 acquisition of a majority stake in STIMIT AG to strengthen its lung-protective ventilation capabilities.VenturelabDräger acquires majority shares of STIMIT to further develop a new therapy for non-invasive stimulation of respiratory muscles – VenturelabDrägerwerk acquired a majority stake in STIMIT, a Swiss medtech startup founded in 2018. STIMIT develops electromagnetic diaphragm stimulation to prevent respiratory muscle weakness during mechanical ventilation. The acquisition aims to expand Dräger's expertise in lung-protective ventilation.